Skip to main content

Table 3 Severity of oral mucositis according to OMAS over time during weeks 1 to 7 for CHX, polyherbal, zinc sulfate, and placebo groups

From: Prevention of radiotherapy-related oral mucositis with zinc and polyherbal mouthwash: a double-blind, randomized clinical trial

Week

Groups

P-value

CHX

Herbal

Zinc sulphate

Placebo

1

0.00 ± 0.00

0.00 ± 0.00

0.00 ± 0.00

0.00 ± 0.00

1.000

2

0.35 ± 0.78

0.00 ± 0.00

0.06 ± 0.24

0.94 ± 1.29

0.001a

3

1.06 ± 1.34

0.23 ± 0.44

0.41 ± 0.79

2.62 ± 2.61

0.003a

4

2.06 ± 2.01

0.65 ± 0.99

0.82 ± 1.28

4.06 ± 3.11

 < 0.001a

5

3.31 ± 2.67

1.58 ± 1.66

1.47 ± 2.03

5.00 ± 3.36

0.001a

6

4.37 ± 2.92

2.12 ± 2.06

2.23 ± 2.82

6.20 ± 3.23

0.001a

7

5.06 ± 2.84

2.58 ± 2.576

2.71 ± 3.33

6.86 ± 3.74

0.002a

  1. Data are based on mean ± SD
  2. The bold values in this table indicates statistically significant difference between four study groups in weeks 2-7, according to OMAS scoring system
  3. aStatistically significant